COLCHESTER HAS ACTIVE PROSTATE SUPPORT

Registered charity 1045849 · accounts filings on the Charity Commission register · also known as CHAPS, UROLOGY RESEARCH IN NORTH ESSEX · listed website unreachable when last crawled

Latest income
£200k
Latest spending
£174k
Registered
1995
Accounts read
FY2023

Financial health, per its FY2023 accounts

The accounts state that unrestricted reserves stood at £54,122, which the trustees intend to maintain at a level covering at least six months of expenditure. The charity reported a net income of £30,222 for the year, derived from charitable activities and donations, with total expenditure on charitable activities amounting to £67,095.

What the accounts disclose

Reserves policy: six months (held: £54k)
It is the intention of the trustees that the level of reserves will cover the expenditure of the charity for a minimum of six months.
Per its FY2023 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit).

Trustees

Trustee list from the Charity Commission register (current, not historical).

Operates in: Essex

Income and spending

Financial year endIncomeSpending
31/03/2025£200k£174k
31/03/2024£117k£108k
31/03/2023£97k£67k
31/03/2022£64k£52k
31/03/2021£16k£37k

Common questions

Is COLCHESTER HAS ACTIVE PROSTATE SUPPORT financially healthy?

The accounts state that unrestricted reserves stood at £54,122, which the trustees intend to maintain at a level covering at least six months of expenditure. The charity reported a net income of £30,222 for the year, derived from charitable activities and donations, with total expenditure on charitable activities amounting to £67,095. Its FY2023 accounts were independently examined.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with COLCHESTER UNITED COMMUNITY FOUNDATION.